Granite Point Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5,000
| Closed | -$422K | – | 68 |
|
|
2019
Q2 | $422K | Buy |
+5,000
| New | +$422K | 0.03% | 58 |
|
|
2015
Q4 | $2.97M | Buy |
+90,000
| New | +$2.97M | 0.44% | 9 |
|
|
2015
Q2 | – | Sell |
-22,000
| Closed | -$674K | – | 98 |
|
|
2015
Q1 | $674K | Hold |
22,000
| – | – | 0.25% | 62 |
|
|
2014
Q4 | $1.12M | Sell |
22,000
-3,000
| -12% | -$153K | 0.52% | 32 |
|
|
2014
Q3 | $989K | Hold |
25,000
| – | – | 0.49% | 40 |
|
|
2014
Q2 | $1.08M | Sell |
25,000
-30,000
| -55% | -$1.29M | 0.74% | 25 |
|
|
2014
Q1 | $2.2M | Sell |
55,000
-5,000
| -8% | -$200K | 1.57% | 13 |
|
|
2013
Q4 | $1.64M | Buy |
+60,000
| New | +$1.64M | 0.27% | 33 |
|